Aratana to attend North American Veterinary Conference February 5-9 and will provides update on availability of ENTYCE® (capromorelin oral solution) via webcast Monday, February 6 at 8 a.m. ET.
Elanco Animal Health, a division of Eli Lilly and Company (NYSE: LLY), and Aratana Therapeutics, Inc. (NASDAQ: PETX) have announced veterinarians have a new targeted tool for the management of pain and inflammation associated with canine osteoarthritis (OA).
The Company was honored with Animal Pharm’s Best Company in North America 2016.
The Company announced its third quarter 2016 financial and operational results.